18 November 2017 : Clinical Research
Overexpression of miR-31 in Peripheral Blood Mononuclear Cells (PBMC) from Patients with Ankylosing Spondylitis
Mengmeng Wang12CE, Li Wang3CD, Xu Zhang12BF, Xiao Yang12B, Xiaona Li12F, Qing Xia12D, Mengya Chen12B, Renfang Han12D, Rui Liu12F, Shengqian Xu4A, Faming Pan12AE*DOI: 10.12659/MSM.905238
Med Sci Monit 2017; 23:5488-5494
Abstract
BACKGROUND: miRNAs play vital roles in regulating immunologic functions and autoimmunity. However, the levels of miR-31, miR-155, miR-16, and miR-181a have not been explored in AS, but were verified to play vital roles in other immunological diseases. The aim of our study was to examine whether the expressions of miR-31, miR-155, miR-16, and miR-181a are abnormal in AS.
MATERIAL AND METHODS: Real-time transcription-polymerase chain reaction analysis (RT-PCR) was used to determine the expression of miR-31, miR-155, miR-16, and miR-181a in peripheral blood mononuclear cells (PBMC) from 40 patients with AS and 40 healthy controls.
RESULTS: The expression of miR-31 was increased in AS patients compared with healthy controls (p=0.001). Furthermore, we detected no significant differences in the expressions of miR-155, miR-16, and miR-181a between AS patients and healthy controls. However, the expression levels of the 4 miRNAs were all significantly different between less active AS and more active AS, with higher levels in more active AS. Moreover, no significant correlations were found between the 4 miRNAs levels with the clinical characteristics in the patients with AS. Interestingly, the expression levels of miR-31, miR-155, and miR-16 in PBMCs were significantly positively correlated with the ESR in new AS patients but not old AS patients.
CONCLUSIONS: Our results suggest that miR-31 is overexpressed in PBMCs of AS patients. Furthermore, miR-31, miR-155, miR-16 and miR-181a may be associated with AS disease activity.
Keywords: Autoimmune Diseases, Spondylitis, Ankylosing
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952